Richard E. Buller - May 17, 2022 Form 4 Insider Report for Celcuity Inc. (CELC)

Role
Director
Signature
/s/ Eric O. Madson as Attorney-in-Fact for Richard E. Buller pursuant to Power of Attorney previously filed.
Stock symbol
CELC
Transactions as of
May 17, 2022
Transactions value $
$0
Form type
4
Date filed
5/19/2022, 08:40 PM
Previous filing
Apr 22, 2022
Next filing
May 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CELC Common Stock Award $0 +3.27K +38.39% $0.00 11.8K May 17, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CELC Stock Option (right to buy) Disposed to Issuer -4.56K -100% 0 May 17, 2022 Common Stock 4.56K $10.68 Direct F2, F4
transaction CELC Stock Option (right to buy) Award +4.56K 4.56K May 17, 2022 Common Stock 4.56K $5.50 Direct F2, F4
transaction CELC Stock Option (right to buy) Disposed to Issuer -2.31K -100% 0 May 17, 2022 Common Stock 2.31K $26.99 Direct F2, F4
transaction CELC Stock Option (right to buy) Award +2.31K 2.31K May 17, 2022 Common Stock 2.31K $5.50 Direct F2, F4
transaction CELC Stock Option (right to buy) Award $0 +19.6K $0.00 19.6K May 17, 2022 Common Stock 19.6K $5.50 Direct F3
holding CELC Stock Option (right to buy) 12.7K May 17, 2022 Common Stock 12.7K $5.10 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 3,273 shares of restricted stock for which risks of forfeiture lapse on April 30, 2023, or if earlier, the date of the Company's 2023 Annual Meeting of Stockholders.
F2 100% vested.
F3 This Option will vest and become exercisable on April 30, 2023, or if earlier, the date of the Company's 2023 Annual Meeting of Stockholders.
F4 The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option.